Akers Biosciences (AKER) Short Interest Ratio & Short Volume → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free AKER Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Akers Biosciences Short Interest DataCurrent Short Volume1,620,000 sharesPrevious Short Volume1,940,000 sharesChange Vs. Previous Month-16.49%Dollar Volume Sold Short$4.96 millionShort Interest Ratio / Days to Cover2.1Last Record DateMarch 31, 2021Outstanding Shares16,653,000 sharesPercentage of Shares Shorted9.73%Today's Trading Volume36,768 sharesAverage Trading Volume769,876 sharesToday's Volume Vs. Average5% Short Selling Akers Biosciences ? Sign up to receive the latest short interest report for Akers Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAKER Short Interest Over TimeAKER Days to Cover Over TimeAKER Percentage of Float Shorted Over Time Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. Akers Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20211,620,000 shares $4.96 million -16.5%N/A2.1 $3.06 3/15/20211,940,000 shares $6.81 million +16.2%N/A2.3 $3.51 2/26/20211,670,000 shares $5.69 million +65.4%18.9%2 $3.41 2/12/20211,010,000 shares $3.73 million +79.6%11.4%1 $3.69 1/29/2021562,500 shares $1.57 million -7.7%6.4%0.4 $2.79 1/15/2021609,100 shares $1.64 million -7.2%7.5%0.5 $2.69 Get the Latest News and Ratings for AKER and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akers Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/31/2020656,200 shares $1.34 million +8.4%8.1%0.5 $2.04 12/15/2020605,400 shares $1.19 million +4.2%7.5%0.5 $1.97 11/30/2020581,200 shares $1.11 million -24.5%7.2%0.4 $1.91 11/15/2020769,600 shares $1.55 million +29.6%9.5%0.5 $2.01 10/30/2020593,900 shares $1.16 million +10.7%7.1%0.7 $1.95 10/15/2020536,600 shares $1.26 million +12.2%6.4%0.6 $2.35 9/30/2020478,200 shares $1.08 million +18.7%5.7%0.4 $2.25 9/15/2020402,800 shares $954,636.00 +86.1%4.8%0.3 $2.37 8/31/2020216,400 shares $545,328.00 +21.8%2.6%0.2 $2.52 8/14/2020177,700 shares $1.08 million -4.3%2.1%0.2 $6.06 7/31/2020185,700 shares $963,783.00 +70.1%3.2%0.1 $5.19 7/15/2020109,200 shares $435,708.00 -14.6%1.9%0.1 $3.99 6/30/2020127,800 shares $444,744.00 +23.2%2.2%0.1 $3.48 6/15/2020103,700 shares $340,136.00 +32.3%1.8%0 $3.28 5/29/202078,400 shares $266,560.00 -17.3%1.8%0 $3.40 5/15/202094,800 shares $332,748.00 -12.1%2.1%0 $3.51 4/30/2020107,800 shares $372,988.00 -37.5%2.4%0.1 $3.46 4/15/2020172,400 shares $672,360.00 +281.4%6.2%0.1 $3.90 3/31/202045,200 shares $96,502.00 +11.1%1.6%0 $2.14 3/13/202040,700 shares $208,791.00 -14.9%8.5%0.3 $5.13 2/28/202047,800 shares $94,644.00 -6.1%10.0%0.3 $1.98 2/14/202050,900 shares $126,741.00 +498.8%10.6%0.3 $2.49 1/31/20208,500 shares $25,755.00 -31.5%1.8%0.1 $3.03 1/15/202012,400 shares $39,432.00 -73.3%2.6%0.1 $3.18 12/31/201946,400 shares $148,480.00 +95.8%12.3%0.4 $3.20 AKER Short Interest - Frequently Asked Questions What is Akers Biosciences' current short interest? Short interest is the volume of Akers Biosciences shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 1,620,000 shares of AKER short. Learn More on Akers Biosciences' current short interest. What is a good short interest ratio for Akers Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKER shares currently have a short interest ratio of 2.0. Learn More on Akers Biosciences's short interest ratio. Is Akers Biosciences' short interest increasing or decreasing? Akers Biosciences saw a decrease in short interest in March. As of March 31st, there was short interest totaling 1,620,000 shares, a decrease of 16.5% from the previous total of 1,940,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Akers Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Akers Biosciences: ImmuCell Co. (0.12%), Aspira Women's Health Inc. (2.94%), Cardio Diagnostics Holdings, Inc. (2.73%), OncoCyte Co. (2.35%), ARCA biopharma, Inc. (1.28%), Trinity Biotech plc (0.06%), Biomerica, Inc. (0.46%), Achieve Life Sciences, Inc. (3.32%), Alpha Teknova, Inc. (0.48%), Marker Therapeutics, Inc. (2.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.58 billion), Charter Communications, Inc. ($5.48 billion), Aon plc ($5.31 billion), Airbnb, Inc. ($3.01 billion), Snap Inc. ($2.99 billion), Warner Bros. Discovery, Inc. ($2.56 billion), The Kroger Co. ($2.29 billion), Expedia Group, Inc. ($2.23 billion), Peloton Interactive, Inc. ($2.19 billion), and GameStop Corp. ($2.03 billion). View all of the most shorted stocks. What does it mean to sell short Akers Biosciences stock? Short selling AKER is an investing strategy that aims to generate trading profit from Akers Biosciences as its price is falling. AKER shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Akers Biosciences? A short squeeze for Akers Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AKER, which in turn drives the price of the stock up even further. How often is Akers Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKER, twice per month. The most recent reporting period available is March, 31 2021. More Short Interest Resources from MarketBeat Related Companies: ImmuCell Short Interest Aspira Women's Health Short Interest Cardio Diagnostics Short Interest OncoCyte Short Interest ARCA biopharma Short Interest Trinity Biotech Short Interest Biomerica Short Interest Achieve Life Sciences Short Interest Alpha Teknova Short Interest Marker Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AKER) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings